Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum

Journal of Immunology

Volumn 168, Issue 6, 2002, Pages 2667-2675

  Golovina, Tatiana N ^a   Wherry, E John ^a   Bullock, Timothy N J ^a   Eisenlohr, Laurence C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPROTEIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; ENDOPLASMIC RETICULUM; EPITOPE MAPPING; FEMALE; INFLUENZA VIRUS; INTRACELLULAR TRANSPORT; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; QUALITATIVE ANALYSIS; QUALITATIVE DIAGNOSIS;

EID: 0037087304     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.6.2667     Document Type: Article

References (73)

1. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness
2. Our immune defense against influenza
3. Role of early viral surface antigens in cellular immune response to vaccinia virus
4. Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes
5. A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone
6. The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells
7. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes
8. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells
9. Immunologia recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells
10. Cytotoxic T cells recognize fragments of the influenza nucleoprotein
11. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
12. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes
13. Introduction of soluble protein into the class I pathway of antigen processing and presentation
14. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules
15. Antigen processing and presentation by the class I major histocompatibility complex
16. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes
17. Mechanisms of MHC class 1-restricted antigen processing
18. Defective presentation to class 1-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen
19. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization
20. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of MHC class I-restricted peptides from the endoplasmic reticulum to the cytosol
21. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation
22. The Listeria monocytogenes-secreted p60 protein is an N-end rule substrate in the cytosol of infected cells: Implications for major histocompatibility complex class 1 antigen processing of bacterial proteins
23. Intracellular localization of proteasomal degradation of a viral antigen
24. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors
25. Degradation of proteins within the endoplasmic reticulum
26. MHC class I-restricted processing of transmembrane proteins
27. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames
28. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
29. Endoplasmic reticulum degradation: Reverse protein flow of no return
30. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein
31. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: Importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes
32. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
33. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules
34. Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: Dependence on TAP1/2 and mechanisms for cytosolic localization
35. Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homolog HsIV by a new class of inhibitors
36. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid
37. d in proteasome subunit LMP2- and LMP7-deficient cells
38. Differential transport requirements of HLA and H-2 class 1 glycoproteins
39. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein
40. Murine TAP preferences influence class I-restricted T cell responses
41. The induction of virus-specific CTL as a function of increasing epitope expression: Responses rise steadily until excessively high levels of epitope are attained
42. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the α-β chain complex
43. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
44. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
45. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
46. LacZ inducible, antigen/MHC-specific T cell hybrids
47. The 26S proteasome
48. The NP1-1/NP1-3 (karyopherin α) binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal
49. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins
50. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
51. Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen
52. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
53. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis
54. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity
55. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
56. k molecule
57. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
58. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors
59. Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence
60. b-restricted epitope from two different strains of influenza virus nucleoprotein
61. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class 1 antigen presentation
62. + T cells
63. + CTL
64. Folding and assembly of viral membrane proteins
65. Class 1-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site: Implications for the mechanism of processing of viral envelope proteins
66. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
67. The MHC class 1 ligand-generating system: Roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28
68. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
69. γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
70. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
71. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol
72. Human lymphoblast and erythrocyte multicatalytic proteases: Differential peptidase activities and responses to the 11S regulator